β2-Glycoprotein I inhibits endothelial cell migration through the nuclear factor κB signalling pathway and endothelial nitric oxide synthase activation

Angiopoietin-2-Driven Vascular Remodeling in Airway Inflammation

(2010) Sebastien P. Tabruyn et al.   AMERICAN JOURNAL OF PATHOLOGY

Naturally occurring free thiols within  2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury

(2010) Y. Ioannou et al.   BLOOD

Plasmin-clipped β2-glycoprotein-I inhibits endothelial cell growth by down-regulating cyclin A, B and D1 and up-regulating p21 and p27

(2010) Wolf-Dietrich C. Beecken et al.   CANCER LETTERS

In vivo modulation of angiogenesis by beta 2 glycoprotein I

(2010) F.H. Passam et al.   JOURNAL OF AUTOIMMUNITY

Oxidative stress enhances AP-1 and NF-κB-mediated regulation of β2-Glycoprotein I gene expression in hepatoma cells

(2010) Wen-Chin Chiu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

TLR2 Is One of the Endothelial Receptors for  2-Glycoprotein I

(2010) J.-E. Alard et al.   JOURNAL OF IMMUNOLOGY

Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells

(2010) Tzu-Ming Wang et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Inactivation of Foxo3a and Subsequent Downregulation of PGC-1  Mediate Nitric Oxide-Induced Endothelial Cell Migration

(2010) S. Borniquel et al.   MOLECULAR AND CELLULAR BIOLOGY

APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome

(2009) Antoni Castro et al.   ATHEROSCLEROSIS

Basal nitric oxide release attenuates cell migration of HeLa and endothelial cells

(2009) Stefania Bulotta et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Nicked  2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property

(2009) H. Nakagawa et al.   BLOOD

Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men

(2009) B. de Laat et al.   BLOOD

The vicious circle between oxidative stress and inflammation in atherosclerosis

(2009) Maarten Hulsmans et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis

(2009) Judith C Sluimer et al.   JOURNAL OF PATHOLOGY

NF- B activation in endothelial cells is critical for the activity of angiostatic agents

(2009) S. P. Tabruyn et al.   MOLECULAR CANCER THERAPEUTICS

NF-κB: a new player in angiostatic therapy

(2008) Sebastien P. Tabruyn et al.   ANGIOGENESIS

Shared Principles in NF-κB Signaling

(2008) Matthew S. Hayden et al.   CELL

Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA1/3, COX-2, and NF-κB activation- and EGFR transactivation-dependent mechanisms

(2008) Chi-Iou Lin et al.   CELLULAR SIGNALLING

ADP Stimulates Human Endothelial Cell Migration via P2Y 1 Nucleotide Receptor–Mediated Mitogen-Activated Protein Kinase Pathways

(2008) Jianzhong Shen et al.   CIRCULATION RESEARCH

The Scavenger Receptor Class B Type I Adaptor Protein PDZK1 Maintains Endothelial Monolayer Integrity

(2008) Weifei Zhu et al.   CIRCULATION RESEARCH

The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis

(2008) Shusheng Wang et al.   DEVELOPMENTAL CELL

NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases

(2008) Fazlul H. Sarkar et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

β2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain

(2008) P. YU et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Nitric oxide and endothelial cellular senescence

(2008) Toshio Hayashi et al.   PHARMACOLOGY & THERAPEUTICS

Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-κB-dependent pathway

(2008) Konstantin Golovine et al.   PROSTATE

Nitric oxide homeostasis as a target for drug additives to cardioplegia

(2007) B K Podesser et al.   BRITISH JOURNAL OF PHARMACOLOGY